BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38770651)

  • 1. Bridging Imaging and Clinical Scores in Parkinson's Progression via Multimodal Self-Supervised Deep Learning.
    Martinez-Murcia FJ; Arco JE; Jimenez-Mesa C; Segovia F; Illan IA; Ramirez J; Gorriz JM
    Int J Neural Syst; 2024 Aug; 34(8):2450043. PubMed ID: 38770651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-View Graph Convolutional Network and Its Applications on Neuroimage Analysis for Parkinson's Disease.
    Zhang X; He L; Chen K; Luo Y; Zhou J; Wang F
    AMIA Annu Symp Proc; 2018; 2018():1147-1156. PubMed ID: 30815157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson's disease.
    Tsiouris KM; Konitsiotis S; Koutsouris DD; Fotiadis DI
    Artif Intell Med; 2020 Mar; 103():101807. PubMed ID: 32143804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's Disease Recognition Using Decorrelated Convolutional Neural Networks: Addressing Imbalance and Scanner Bias in rs-fMRI Data.
    Patil P; Ford WR
    Biosensors (Basel); 2024 May; 14(5):. PubMed ID: 38785733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
    Zhang X; Chou J; Liang J; Xiao C; Zhao Y; Sarva H; Henchcliffe C; Wang F
    Sci Rep; 2019 Jan; 9(1):797. PubMed ID: 30692568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint regression and classification via relational regularization for Parkinson's disease diagnosis.
    Lei H; Huang Z; Han T; Luo Q; Cai Y; Liu G; Lei B
    Technol Health Care; 2018; 26(S1):19-30. PubMed ID: 29689760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cognitive decline prediction based on multi-modal data using Multimodal3DSiameseNet: transfer learning from Alzheimer's disease to Parkinson's disease.
    Ostertag C; Visani M; Urruty T; Beurton-Aimar M
    Int J Comput Assist Radiol Surg; 2023 May; 18(5):809-818. PubMed ID: 36964477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal Classification of Parkinson's Disease in Home Environments with Resiliency to Missing Modalities.
    Heidarivincheh F; McConville R; Morgan C; McNaney R; Masullo A; Mirmehdi M; Whone AL; Craddock I
    Sensors (Basel); 2021 Jun; 21(12):. PubMed ID: 34208690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explainable machine learning models based on multimodal time-series data for the early detection of Parkinson's disease.
    Junaid M; Ali S; Eid F; El-Sappagh S; Abuhmed T
    Comput Methods Programs Biomed; 2023 Jun; 234():107495. PubMed ID: 37003039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging genetics approach to Parkinson's disease and its correlation with clinical score.
    Kim M; Kim J; Lee SH; Park H
    Sci Rep; 2017 Apr; 7():46700. PubMed ID: 28429747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
    Dean DC; Sojkova J; Hurley S; Kecskemeti S; Okonkwo O; Bendlin BB; Theisen F; Johnson SC; Alexander AL; Gallagher CL
    PLoS One; 2016; 11(10):e0163774. PubMed ID: 27706215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-supervised multimodal learning for group inferences from MRI data: Discovering disorder-relevant brain regions and multimodal links.
    Fedorov A; Geenjaar E; Wu L; Sylvain T; DeRamus TP; Luck M; Misiura M; Mittapalle G; Hjelm RD; Plis SM; Calhoun VD
    Neuroimage; 2024 Jan; 285():120485. PubMed ID: 38110045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural Networks.
    Chan YH; Wang C; Soh WK; Rajapakse JC
    Front Neurosci; 2022; 16():866666. PubMed ID: 35677355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's Disease Diagnosis via Joint Learning From Multiple Modalities and Relations.
    Lei H; Huang Z; Zhou F; Elazab A; Tan EL; Li H; Qin J; Lei B
    IEEE J Biomed Health Inform; 2019 Jul; 23(4):1437-1449. PubMed ID: 30183649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning architectures for Parkinson's disease detection by using multi-modal features.
    Pahuja G; Prasad B
    Comput Biol Med; 2022 Jul; 146():105610. PubMed ID: 35659446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis.
    Conrado DJ; Nicholas T; Tsai K; Macha S; Sinha V; Stone J; Corrigan B; Bani M; Muglia P; Watson IA; Kern VD; Sheveleva E; Marek K; Stephenson DT; Romero K;
    Clin Transl Sci; 2018 Jan; 11(1):63-70. PubMed ID: 28749580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.